1
Clinical Trials associated with N-IP-00001A Randomized, Double-blind, Placebo-controlled, Dose-escalation Phase I Safety Study of Inhaled N-IP-00001 to Determine Tolerability and Safety in Healthy Volunteers.
Randomized, double-blind, placebo-controlled, dose-escalation Phase I safety study of inhaled N-IP-00001, to determine tolerability and safety in healthy volunteers.
100 Clinical Results associated with N-IP-00001
100 Translational Medicine associated with N-IP-00001
100 Patents (Medical) associated with N-IP-00001
100 Deals associated with N-IP-00001